• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Fampridine Teva
    / Teva Israel LTD, Israel


    Active Ingredient
    Fampridine 10 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Prolonged-Release Tablets

    28 x 10 mg

    partial basket chart

    Prolonged-Release Tablets

    56 x 10 mg

    partial basket chart

    Related information


    Dosage

    The recommended dose is one 10 mg tablet, twice daily, taken 12 hours apart (one tablet in thprole morning and one tablet in the evening).


    Indications

    Fampridine Teva is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7)


    Contra-Indications

    * Hypersensitivity to the active substance or to any of the excipients.
    * Patients with prior history or current presentation of seizure.
    * Patients with mild, moderate or severe renal impairment.
    * Concomitant use of fampridine with medicinal products contains cimetidine.
    * Concurrent treatment with other medicinal products containing fampridine.


    Special Precautions

    Please refer to the license holder for further details


    Side Effects

    Please refer to the license holder for further details


    Drug interactions

    Please refer to the license holder for further details


    Pregnancy and Lactation

    Please refer to the license holder for further details


    Overdose

    Please refer to the license holder for further details


    Manufacturer
    Teva Israel LTD, Israel
    CLOSE